16-546938-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005632.3(CAPN15):c.100G>A(p.Asp34Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000354 in 1,610,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000034 ( 0 hom. )
Consequence
CAPN15
NM_005632.3 missense
NM_005632.3 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 7.99
Genes affected
CAPN15 (HGNC:11182): (calpain 15) This gene encodes a protein containing zinc-finger-like repeats and a calpain-like protease domain. The encoded protein may function as a transcription factor, RNA-binding protein, or in protein-protein interactions during visual system development. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.34351027).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN15 | NM_005632.3 | c.100G>A | p.Asp34Asn | missense_variant | 4/14 | ENST00000219611.7 | NP_005623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN15 | ENST00000219611.7 | c.100G>A | p.Asp34Asn | missense_variant | 4/14 | 1 | NM_005632.3 | ENSP00000219611 | P1 | |
CAPN15 | ENST00000637507.1 | c.304G>A | p.Asp102Asn | missense_variant | 2/2 | 5 | ENSP00000490480 | |||
CAPN15 | ENST00000562370.5 | c.100G>A | p.Asp34Asn | missense_variant | 3/3 | 2 | ENSP00000456017 | |||
CAPN15 | ENST00000568988.5 | c.-314-621G>A | intron_variant | 3 | ENSP00000457030 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152228Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
8
AN:
152228
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245654Hom.: 0 AF XY: 0.0000372 AC XY: 5AN XY: 134274
GnomAD3 exomes
AF:
AC:
8
AN:
245654
Hom.:
AF XY:
AC XY:
5
AN XY:
134274
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000336 AC: 49AN: 1458410Hom.: 0 Cov.: 32 AF XY: 0.0000345 AC XY: 25AN XY: 725682
GnomAD4 exome
AF:
AC:
49
AN:
1458410
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
725682
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152228Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74362
GnomAD4 genome
AF:
AC:
8
AN:
152228
Hom.:
Cov.:
34
AF XY:
AC XY:
4
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2024 | The c.100G>A (p.D34N) alteration is located in exon 4 (coding exon 1) of the CAPN15 gene. This alteration results from a G to A substitution at nucleotide position 100, causing the aspartic acid (D) at amino acid position 34 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Pathogenic
D;D;.
Polyphen
1.0
.;D;.
Vest4
0.68
MutPred
Loss of ubiquitination at K32 (P = 0.0431);Loss of ubiquitination at K32 (P = 0.0431);.;
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at